Silvergate researches, develops and commercializes pediatric medications... Read more
Silvergate researches, develops and commercializes pediatric medications... Read more
President & CEO
Neal I. Muni
News
Jun 25, 2019
The Business Journals: Denver
Silvergate: Massachusetts company acquires and renames Colorado-based pharmaceutical business
Jun 24, 2019
The Business Journals: Kansas City
Silvergate: Massachusetts company acquires pharmaceutical business with OP facility
Jun 12, 2019
BioPortfolio
Silvergate: CutisPharma Announces Acquisition of Silvergate Pharmaceuticals Name Change to Azurity Pharmaceuticals
Jul 30, 2017
BioPortfolio
Silvergate: Silvergate Pharmaceuticals announces Xatmep availability
Apr 25, 2017
BioSpace
Silvergate: Silvergate Pharmaceuticals Release: FDA Approves XATMEP, The First and Only Ready-To-Use Methotrexate Oral Solution
Jan 11, 2017
BioSpace
Silvergate: Silvergate Pharmaceuticals Release: EPANED (Enalapril Maleate) Oral Solution 1 Mg/Ml, The First And Only FDA-Approved Enalapril Oral Solution For The Treatment Of Pediatric Hypertension In Patients Older Than 1 Month, Is Now Available
Oct 26, 2016
BioSpace
Silvergate: Silvergate Pharmaceuticals Release: Qbrelis, The First And Only Lisinopril Oral Solution 1 Mg/Ml For Pediatric Patients 6 Years Of Age And Older, Is Now Available
Aug 01, 2016
BioSpace
Silvergate: Silvergate Pharmaceuticals Release: FDA Approves Qbrelis, The First And Only Lisinopril Oral Solution 1 Mg/Ml For Pediatric Patients 6 Years Of Age And Older
Jul 30, 2016
The Pharma Letter
Silvergate: FDA approves Silvergate's pediatric lisinopril Qbrelis
Sep 09, 2014
BIOPORTFOLIO
Silvergate: FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure
Silvergate Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10